Clioquinol (5-chloro-7-iodoquinolin-8-ol) was originally identified as a copper/zinc chelator and ameliorated both amyloid pathology and cognitive loss in APP transgenic models of AD (67, 68). This evidence concerns the gene APP and Alzheimer disease.